Anterix Inc.
83.93USD
-1.5100 (-1.77%)
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $-0.28▼ | $-0.24 | 0 | 0 |
| Next quarter | $-0.21▲ | $-0.23 | 0 | 0 |
| Current year | $-1.11▲ | $-1.33 | 0 | 0 |
| Next year | $-0.59▼ | $0 | 0 | 1 |
Beat in 3 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | $-0.17 | $0.01 | +0.18 (+106.1%) |
| 2026-03-31 | $1.37 | $0.98 | -0.39 (-28.5%) |
| 2025-12-31 | $-0.55 | $-0.35 | +0.20 (+36.4%) |
| 2025-09-30 | $-0.6 | $2.86 | +3.46 (+576.7%) |
21 ratings from 3 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| JP Morgan | Maintained | Overweight | $133 $130 | Aug 13, 2026 |
| JP Morgan | Maintained | Overweight | $50 $133 | Jul 20, 2026 |
| B. Riley Securities | Downgraded from Buy | Neutral | $44 $69 | Jun 4, 2026 |
| JP Morgan | Maintained | Overweight | $67 $50 | Oct 17, 2025 |
| JP Morgan | Maintained | Overweight | $61 $67 | Feb 13, 2025 |
| JP Morgan | Maintained | Overweight | $60 $61 | Aug 8, 2024 |
| B. Riley Securities | Maintained | Buy | $75 | Feb 16, 2024 |
| Morgan Stanley | Maintained | Equal-Weight | $42 $41 | Aug 1, 2023 |
| Morgan Stanley | Maintained | Equal-Weight | $63 $42 | Feb 24, 2023 |
| Morgan Stanley | Maintained | Equal-Weight | $65 $63 | Feb 10, 2022 |
| Morgan Stanley | Maintained | Equal-Weight | $51 $65 | Aug 4, 2021 |
| Morgan Stanley | Maintained | Equal-Weight | $48 $51 | Jun 9, 2021 |
| JP Morgan | Upgraded from Neutral | Overweight | $40 $50 | Feb 17, 2021 |
| JP Morgan | Upgraded from Underweight | Neutral | $30 $40 | Feb 1, 2021 |
| Morgan Stanley | Maintained | Equal-Weight | $50 $48 | Jan 27, 2021 |
| JP Morgan | Downgraded from Neutral | Underweight | $30 | Nov 18, 2020 |
| Morgan Stanley | Maintained | Equal-Weight | $51 $50 | Jul 1, 2020 |
| B. Riley Securities | Maintained | Buy | $59 $75 | May 22, 2020 |
| Morgan Stanley | Maintained | Equal-Weight | $50 $51 | Feb 20, 2020 |
| JP Morgan | Initiated | Neutral | $58 | Feb 3, 2020 |
| Morgan Stanley | Initiated | Equal-Weight | $50 | Nov 11, 2019 |
61 filings from 14 insiders · 20 buy / 13 sell over 6m
Officers and directors of ATEX, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Ashe Gena LOfficer, Chief Legal Officer & Corp Sec | Sell | 4.1k | $85.44 | $347k | Sep 8, 2026 |
| Ashe Gena LOfficer, Chief Legal Officer & Corp Sec | Sell | 293 | $85.44 | $25k | Sep 8, 2026 |
| DANIELS LESLIE BDirector | Sell | 1.2k | $86.50 | $104k | Sep 4, 2026 |
| DANIELS LESLIE BDirector | Sell | 2.9k | $87.31 | $253k | Sep 4, 2026 |
| DANIELS LESLIE BDirector | Sell | 6.0k | $87.15 | $523k | Sep 3, 2026 |
| GUTTMAN-MCCABE CHRISTOPHEROfficer | Sell | 23.4k | $90.61 | $2.16M | Aug 25, 2026 |
| GUTTMAN-MCCABE CHRISTOPHEROfficer | Exercise | 40.0k | $37.42 | $1.50M | Aug 25, 2026 |
| KUHN THOMAS RDirector | Sell | 11.7k | $79.52 | $1.02M | Aug 24, 2026 |
| KUHN THOMAS RDirector | Exercise | 10.0k | $33.62 | $336k | Aug 24, 2026 |
| HEARD WILLIAMDirector | Gift | 5.4k | — | — | Aug 19, 2026 |
| LANG SCOTT AChief Executive Officer | Sell | 35.1k | $88.96 | $3.16M | Aug 14, 2026 |
| HEARD WILLIAMDirector | Sellindirect | 46.4k | $90.11 | $4.18M | Aug 14, 2026 |
| HEARD WILLIAMDirector | Grant | 1.6k | — | — | Aug 4, 2026 |
| FLEISCHHAUER MARK A.Director | Grant | 1.6k | — | — | Aug 4, 2026 |
| YAZDI MAHVASHDirector | Grant | 1.6k | — | — | Aug 4, 2026 |
| ALTMAN JEFFREY A.Director and Beneficial Owner of more than 10% of a Class of Security | Grant | 1.6k | — | — | Aug 4, 2026 |
| DANIELS LESLIE BDirector | Grant | 1.6k | — | — | Aug 4, 2026 |
| LANG SCOTT AChief Executive Officer | Sell | 170 | $80.25 | $14k | Jun 18, 2026 |
| MARQUEZ ELENAChief Financial Officer | Sell | 4.3k | $79.50 | $341k | Jun 17, 2026 |
| MARQUEZ ELENAChief Financial Officer | Exercise | 1.2k | $40.00 | $49k | Jun 17, 2026 |
No analyst notes on ATEX yet.
Analyst Ratings
3 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 1 | 1 | 1 | 0 | 0 | Buy2.00 |
| 1 mo ago | 1 | 1 | 1 | 0 | 0 | Buy2.00 |
| 2 mo ago | 1 | 1 | 1 | 0 | 0 | Buy2.00 |